Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | Discussing treatment on a global scale: creating a worldwide understanding

Irene Ghobrial • 10 Dec 2017
ASH 2017
General

The primary focus is often on treatment within the United States or Europe, but what about treatment on a global scale? Here, Irene Ghobrial, MD, of the Dana-Farber Cancer Institute, Boston, MA, offers her thoughts on extending the understanding of how diseases are treated across the globe. Dr Ghobrial discusses an initiative that she will be involved in whilst in Egypt, with hopes to expand across Africa and the Middle East. She also considers the possible complications with the idea, but emphasizes that all patients, worldwide, need to benefit from treatment equally. This video was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.

More from Irene Ghobrial

0:52
Using spatial proteomics to analyze the bone marrow microenvironment in SMM treated with nivolumab
Irene Ghobrial • 7 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
Early interception in SMM & novel agents being explored
Irene Ghobrial et al. • 25 Mar 2024
1:19
Single-cell sequencing of circulating tumor cells to predict progression from MGUS/SMM
Irene Ghobrial • 11 Dec 2023

Related Videos

1:46
Assessing PFS and alternative endpoints for advanced cancer clinical trials
Jurjen Versluis • 22 Apr 2024
1:15
Reducing steroid usage in the treatment of lower-risk GvHD
James Ferrara • 16 Apr 2024
1:02
The MAGIC model: a day 14 endpoint for acute GvHD clinical trials
James Ferrara • 16 Apr 2024
1:19
Mitigating the potential complications of CAR-T therapy: important supportive care measures
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals